Insulin Resistance and Metabolic Health
Insulin resistance occurs when the body's cells become less responsive to insulin, the hormone that moves glucose from the bloodstream into cells for energy. To compensate, the pancreas produces increasing amounts of insulin to maintain normal blood glucose levels. Over time, this compensatory mechanism places significant strain on metabolic function. It can progress toward prediabetes, type 2 diabetes, and a broader pattern of metabolic dysfunction affecting cardiovascular health, hormone balance, cognitive function, and energy production at a cellular level.
Insulin resistance rarely announces itself early. Blood glucose can remain within a normal reference range for years while insulin levels quietly climb in the background, meaning many people are well into the process before it becomes visible on standard pathology.
Understanding what is happening
Insulin Resistance
One of the most clinically significant aspects of insulin resistance is how long it can be present before showing up on standard testing. Fasting glucose and HbA1c — the two markers most commonly used to assess blood sugar — are typically the last to shift. By the time they move outside the normal range, insulin has often been elevated for years.
Fasting insulin, HOMA-IR, and the triglyceride-glucose index are more sensitive early markers that reflect what is actually happening in the metabolic system before conventional testing flags a problem.
The symptoms of insulin resistance are often attributed to other causes — tiredness to poor sleep, weight gain to diet, brain fog to stress. This is why identifying the metabolic picture early requires looking at the right markers, not just waiting for glucose to shift.
Normal blood sugar.
Something still feels off.
Conditions We Support
A functional medicine perspective on insulin resistance
Insulin resistance is not simply a consequence of diet or body weight. It is a systemic pattern that develops through the interaction of multiple physiological systems, and effective correction depends on identifying which of these systems are contributing in a given individual.
Common Presentations
Contributing factors we investigate
Chronic stress and HPA axis dysfunction
Elevated cortisol directly antagonises insulin signalling and promotes glucose release from the liver, meaning unresolved stress physiology can drive insulin resistance independently of diet. This is one reason lifestyle changes alone often produce incomplete results when cortisol patterns are not addressed.
Inflammatory load
Chronic low-grade inflammation, whether from gut dysfunction, hidden infection, or other sources, interferes with insulin receptor signalling at the cellular level. This inflammatory pathway is one reason metabolic dysfunction is so closely linked to gut health.
Sleep disruption
Poor sleep quality and inadequate sleep duration are strongly associated with reduced insulin sensitivity, even over relatively short periods. Sleep is one of the most powerful and underutilised levers for metabolic health, and correcting sleep patterns is often a necessary part of any metabolic protocol.
Gut health and the microbiome
Dysbiosis and intestinal permeability have been shown to contribute to systemic inflammation and altered glucose metabolism. The gut microbiome directly influences how dietary carbohydrates are processed and how much inflammatory signalling reaches the liver and muscle tissue.
Muscle mass and body composition
Skeletal muscle is the primary site of glucose disposal in the body. Reduced muscle mass, common with sedentary lifestyles and ageing, reduces the body's overall capacity to clear glucose efficiently. This is why body composition assessment and resistance training are central to metabolic health management.
Hormonal factors
Sex hormone imbalances, thyroid dysfunction, and perimenopause or menopause can all influence insulin sensitivity. This is one reason metabolic dysfunction often worsens around hormonal transitions and why investigating hormonal status is part of a complete metabolic assessment.
Beneath the Surface
How Wave Functional Health approaches Insulin Resistance
Assessment at Wave begins with detailed functional blood chemistry analysis, looking beyond standard reference ranges to identify early patterns of insulin resistance well before they would be flagged on conventional pathology. Key markers assessed include fasting insulin, HOMA-IR, and the triglyceride-glucose index, which together provide a much clearer picture of insulin sensitivity than fasting glucose or HbA1c alone.
Body composition is assessed using InBody 580 analysis, providing precise measurement of skeletal muscle mass, visceral fat, and body fat percentage — all of which are directly relevant to insulin sensitivity and metabolic risk. This gives both a functional metabolic picture and an objective baseline to track real change over time.
This is a proactive, root-cause approach designed to identify and address metabolic dysfunction early, rather than waiting for a diabetes diagnosis to intervene.
Functional blood chemistry assessment
Fasting insulin, HOMA-IR, triglyceride-glucose index, HbA1c, lipid panel, and inflammatory markers assessed at functional reference ranges — providing a detailed metabolic picture that standard pathology alone does not capture.
InBody 580 body composition analysis
Precise measurement of skeletal muscle mass, visceral fat, and body fat percentage — directly relevant to insulin sensitivity and providing an objective baseline for tracking change throughout the programme.
Correction of underlying drivers
Addressing HPA axis dysfunction, inflammatory load, gut health, and hormonal factors that are maintaining insulin resistance independent of diet and exercise — because these cannot be resolved by nutrition alone.
Structured nutrition and resistance training
Nutrition guidance tailored to the individual metabolic context alongside resistance training strategies to build skeletal muscle mass — the primary site of glucose disposal and one of the most powerful levers for long-term insulin sensitivity.
Sleep optimisation
Sleep is one of the most powerful and underutilised levers for insulin sensitivity. Correcting sleep quality and duration is a core part of any metabolic protocol at Wave, not an afterthought.
Ongoing monitoring and retesting
Functional blood chemistry and body composition analysis at review points to track real metabolic change over time — not just how someone feels, but what the objective markers are showing.
Advance Testing
What we assess for Insulin Resistance
← Scroll to see full table
| Test | What it reveals |
|---|---|
| Fasting Insulin | The most sensitive early marker of insulin resistance — often significantly elevated while fasting glucose remains completely normal. This is the window where metabolic dysfunction begins and where early intervention is most effective |
| HOMA-IR | A calculated index using fasting insulin and fasting glucose that provides a composite picture of insulin resistance. More sensitive than either marker alone and allows tracking of improvement over time |
| Triglyceride-Glucose (TyG) Index | A validated surrogate marker of insulin resistance calculated from fasting triglycerides and fasting glucose. Particularly useful for identifying metabolic risk in people who appear normal on standard lipid panels |
| HbA1c and Fasting Glucose | Standard markers of blood glucose regulation — assessed alongside functional markers for a complete picture. These are often the last to shift and do not reflect insulin resistance in its early stages |
| InBody 580 Body Composition | Precise measurement of skeletal muscle mass, visceral fat, body fat percentage, and segmental analysis — directly relevant to insulin sensitivity and providing an objective baseline and progress measure throughout the programme |
| DUTCH Complete Hormone Testing | Full cortisol curve, adrenal function, and sex hormone status — assessing the HPA axis and hormonal contributors to insulin resistance that functional blood chemistry alone does not capture |
| GI MAP Stool Analysis | Gut microbiome health, intestinal permeability, and inflammatory markers — assessing the gut-metabolic axis and the inflammatory drivers of insulin resistance that originate in gut dysfunction |
| Inflammatory Markers | High-sensitivity CRP, ferritin, and other inflammatory indicators assessed at functional thresholds — identifying the chronic low-grade inflammatory load that interferes with insulin receptor signalling |
Who This Is For
This approach may suit you if…
Frequently Asked Questions
What people ask about insulin resistance care at Wave
Yes. Fasting glucose and HbA1c often remain within the normal range for years while insulin levels rise to compensate. The pancreas produces more insulin to keep blood glucose looking normal — which is why glucose alone is a poor early marker of insulin resistance.
Fasting insulin, HOMA-IR, and the triglyceride-glucose index are more sensitive early markers that reflect what is actually happening in the metabolic system before conventional testing shows a problem.
No. Insulin resistance is an earlier stage in a progressive process. The pancreas can compensate by producing more insulin for years before blood glucose eventually rises above the diabetic threshold. Left unaddressed, this progression can lead to prediabetes and eventually type 2 diabetes.
The window of insulin resistance — before glucose shifts — is where early intervention is most effective. This is why identifying it early through functional markers matters significantly.
No. While excess body fat, particularly visceral fat, is a significant contributing factor, insulin resistance can also occur in lean people — particularly when muscle mass is low, when chronic stress is present, when sleep is consistently poor, or when gut dysfunction is driving systemic inflammation.
This is why body composition analysis, which distinguishes between muscle mass and fat mass, is more informative than weight or BMI alone in metabolic assessment.
Many people see significant improvement in insulin sensitivity through targeted correction of underlying drivers, appropriate nutrition, resistance training, and improved sleep. The degree of improvement depends on how long the pattern has been present, individual circumstances, and which contributing factors are addressed.
Identifying the specific drivers in a given individual — rather than applying a generic diet — is what determines how completely and sustainably the pattern can be corrected.
Fasting insulin, HOMA-IR, and the triglyceride-glucose index are more sensitive early markers than fasting glucose or HbA1c alone, which typically become abnormal only after significant dysfunction is already present.
InBody 580 body composition analysis adds a further dimension by identifying low muscle mass and elevated visceral fat — both of which are directly relevant to insulin sensitivity and metabolic risk — independently of what the blood markers show.
Maybe it Might Be Something Else?
Normal blood glucose is not
the same as a healthy metabolism.
At Wave Functional Health we use fasting insulin, HOMA-IR, the triglyceride-glucose index, and InBody 580 body composition analysis to identify metabolic dysfunction early and build a targeted plan around what your results actually show.
Book a ConsultationConsultations available in clinic in Robina Gold Coast and worldwide via telehealth.